Gastroenteritis Market Size, Share, Treatment, Symptoms, Analysis, Segmented Overview and Outlook, Pipeline Review, H1 2016

Hexa Reports
Market Research Reports and Insightful Company Profiles
Gastroenteritis Market Size, Share, Treatment, Symptoms,
Analysis, Segmented Overview and Outlook, Pipeline
Review, H1 2016
Global Markets Direct's, 'Gastroenteritis - Pipeline Review, H1 2016', provides an overview of the
Gastroenteritis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for
Gastroenteritis, complete with analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and development history and latest
news and press releases. Additionally, the report provides an overview of key players involved in
therapeutic development for Gastroenteritis and features dormant and discontinued projects.
Browse Detail Report With TOC @ http://www.hexareports.com/report/gastroenteritis-pipelinereview-h1-2016/details
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic
review following a stringent set of processes to ensure that all the profiles are updated with the latest
set of information. Additionally, various dynamic tracking processes ensure that the most recent
developments are captured on a real time basis.
Hexa Reports
Market Research Reports and Insightful Company Profiles
The report helps in identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter strategies to gain
competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance
of data.
Scope
- The report provides a snapshot of the global therapeutic landscape of Gastroenteritis
- The report reviews pipeline therapeutics for Gastroenteritis by companies and universities/research
institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product
description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental
activities
- The report reviews key players involved Gastroenteritis therapeutics and enlists all their major and
minor projects
- The report assesses Gastroenteritis therapeutics based on drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Gastroenteritis
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D
strategies
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for
Gastroenteritis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline
therapeutics
- Devise corrective measures for pipeline projects by understanding Gastroenteritis pipeline depth and
focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors
that drove them from pipeline
Hexa Reports
Market Research Reports and Insightful Company Profiles
Request A Sample copy of This Report @ http://www.hexareports.com/sample/119073
Table of Contents
Table of Content 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Gastroenteritis Overview 6
Therapeutics Development 7
Pipeline Products for Gastroenteritis - Overview 7
Pipeline Products for Gastroenteritis - Comparative Analysis 8
Gastroenteritis - Therapeutics under Development by Companies 9
Gastroenteritis - Therapeutics under Investigation by Universities/Institutes 11
Gastroenteritis - Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Gastroenteritis - Products under Development by Companies 15
Gastroenteritis - Products under Investigation by Universities/Institutes 16
Gastroenteritis - Companies Involved in Therapeutics Development 17
Nanotherapeutics, Inc. 17
RedHill Biopharma Ltd. 18
Takeda Pharmaceutical Company Limited 19
UMN Pharma Inc. 20
Gastroenteritis - Therapeutics Assessment 21
Assessment by Monotherapy Products 21
Assessment by Target 22
Assessment by Mechanism of Action 23
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
Antibodies for Gastroenteritis - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Antibodies to Target TRIM-21 for Gastrointestinal and Ear Nose Throat Disorders - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Hexa Reports
Market Research Reports and Insightful Company Profiles
norovirus (bivalent) virus like particle vaccine - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Browse Full
2016/details
Report
@
http://www.hexareports.com/report/gastroenteritis-pipeline-review-h1-
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Visit Our Blogs: http://hexareports.blogspot.in

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.